What does Rna do?
RNA specializes in the development and production of innovative RNA-based therapeutics and diagnostics. The company focuses on harnessing the potential of RNA technology to address unmet medical needs in various diseases. Additionally, RNA collaborates with academic institutions and industry partners to advance its research and product pipeline.
- Activities
-
No results found
- Signals
-
Reporting lossesReporting losses € -61K
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -39KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -42KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 1.27MStrong equity provides a buffer against setbacks.
Low riskLow risk 86.6%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 6.98A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
- Investments
- Comotis 90%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-26K
|
€
-511
|
€
6K
|
€
13K
|
|
|
€
-42K
|
€
-8K
|
€
-5K
|
€
6K
|
|
|
€
-61K
|
€
-19K
|
€
-19K
|
€
-16K
|
|
|
€
1.27M
|
€
1.33M
|
€
1.35M
|
€
1.28M
|
|
|
86.57%
|
84.55%
|
82.10%
|
77.87%
|
|
|
€
197K
|
€
243K
|
€
294K
|
€
364K
|
|
|
€
204K
|
€
323K
|
€
537K
|
€
612K
|
Publications 45
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) 07/12/2023
- Demissions, Nominations 19/07/2023
- Siege Social 24/08/2022
- Capital, Actions 14/10/2019
- Siege Social 19/02/2019
Frequently asked questions
Answers to the most common questions about Rna, based on official government data and the filed annual accounts.
What is the VAT number of Rna?
The VAT number of Rna is BE0422.891.690.
When was Rna established?
Rna was founded in 14-06-1982.
What is the official address of Rna?
The official address of Rna is Egide Van Ophemstraat 40C Ukkel 1180.
What is the legal form of Rna?
The juridical form of Rna is Public limited company (NV/SA).
What is the annual revenue of Rna?
The 2025 accounts of Rna do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Rna do?
RNA specializes in the development and production of innovative RNA-based therapeutics and diagnostics. The company focuses on harnessing the potential of RNA technology to address unmet medical needs in various diseases. Additionally, RNA collaborates with academic institutions and industry partners to advance its research and product pipeline.
Is Rna a reliable company?
Rna is a registered Rechtspersoon with company number 0422.891.690 and can be verified through the official CBE database.
What is the credit limit of Rna?
The estimated credit limit of Rna is €61,757.
Is Rna still active?
Rna currently has the status "Normal situation" and is active.